# Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

> **NCT01376089** · PHASE4 · COMPLETED · sponsor: **GE Healthcare** · enrollment: 304 (actual)

## Conditions studied

- Patient Comfort and Safety

## Interventions

- **DRUG:** Iodixanol
- **DRUG:** Iopamidol

## Key facts

- **NCT ID:** NCT01376089
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-10
- **Final completion:** 2012-02
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2013-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376089, "Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01376089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*